These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17302677)

  • 1. The traditional herbal medicine Hochuekkito improves systemic inflammation in patients with chronic obstructive pulmonary disease.
    Shinozuka N; Tatsumi K; Nakamura A; Terada J; Kuriyama T
    J Am Geriatr Soc; 2007 Feb; 55(2):313-4. PubMed ID: 17302677
    [No Abstract]   [Full Text] [Related]  

  • 2. Hochuekkito improves systemic inflammation and nutritional status in elderly patients with chronic obstructive pulmonary disease.
    Tatsumi K; Shinozuka N; Nakayama K; Sekiya N; Kuriyama T; Fukuchi Y
    J Am Geriatr Soc; 2009 Jan; 57(1):169-70. PubMed ID: 19170793
    [No Abstract]   [Full Text] [Related]  

  • 3. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F; Kirdar S; Karul AB; Ceylan E
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment.
    Parnham MJ; Culić O; Eraković V; Munić V; Popović-Grle S; Barisić K; Bosnar M; Brajsa K; Cepelak I; Cuzić S; Glojnarić I; Manojlović Z; Novak-Mircetić R; Oresković K; Pavicić-Beljak V; Radosević S; Sucić M
    Eur J Pharmacol; 2005 Jul; 517(1-2):132-43. PubMed ID: 15964564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating visfatin in chronic obstructive pulmonary disease.
    Liu X; Ji Y; Chen J; Li S; Luo F
    Nutrition; 2009 Apr; 25(4):373-8. PubMed ID: 19056239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of clinical effect on treatment of chronic obstructive pulmonary disease in acute aggravated stage with Tanreqing injection and cell factor level].
    Gong G; Li X
    Zhongguo Zhong Yao Za Zhi; 2009 Jan; 34(1):104-6. PubMed ID: 19382463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
    Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
    Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemoglobin, erythropoietin and systemic inflammation in exacerbations of chronic obstructive pulmonary disease.
    Markoulaki D; Kostikas K; Papatheodorou G; Koutsokera A; Alchanatis M; Bakakos P; Gourgoulianis KI; Roussos C; Koulouris NG; Loukides S
    Eur J Intern Med; 2011 Feb; 22(1):103-7. PubMed ID: 21238904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease.
    Schinzari F; Armuzzi A; De Pascalis B; Mores N; Tesauro M; Melina D; Cardillo C
    Clin Pharmacol Ther; 2008 Jan; 83(1):70-6. PubMed ID: 17507924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.
    Kunisaki KM; Rice KL; Janoff EN; Rector TS; Niewoehner DE
    Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Danggui-Buxue-Tang decoction has an anti-inflammatory effect in diabetic atherosclerosis rat model.
    Zhang H; Chen S; Deng X; Yang X; Huang X
    Diabetes Res Clin Pract; 2006 Nov; 74(2):194-6. PubMed ID: 16713007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biomarkers of systemic inflammation, oxidative stress and their interactions in patients with combined flow of chronic obstructive pulmonary disease and arterial hypertension].
    Kryvenko V
    Georgian Med News; 2013 Mar; (216):23-8. PubMed ID: 23567304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients.
    Crul T; Spruit MA; Gayan-Ramirez G; Quarck R; Gosselink R; Troosters T; Pitta F; Decramer M
    Eur J Clin Invest; 2007 Nov; 37(11):897-904. PubMed ID: 17883420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New pharmacological options in the therapy of COPD].
    Watz H; Kanniess F; Magnussen H
    Pneumologie; 2007 Jun; 61(6):365-73. PubMed ID: 17492578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Survey of study on therapeutic mechanism of chronic obstructive pulmonary disease treated by traditional Chinese medicine].
    Jiang YX; Wu JF; Du J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Sep; 25(9):860-4. PubMed ID: 16248256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of inhaled and oral corticosteroids on serum inflammatory biomarkers in COPD: an exploratory study.
    Man SF; Xuekui Zhang ; Vessey R; Walker T; Lee K; Park D; Sin DD
    Ther Adv Respir Dis; 2009 Apr; 3(2):73-80. PubMed ID: 19465442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-alpha blockade.
    Ingegnoli F; Fantini F; Favalli EG; Soldi A; Griffini S; Galbiati V; Meroni PL; Cugno M
    J Autoimmun; 2008 Sep; 31(2):175-9. PubMed ID: 18707846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging trends in the therapy of COPD: novel anti-inflammatory agents in clinical development.
    Fitzgerald MF; Fox JC
    Drug Discov Today; 2007 Jun; 12(11-12):479-86. PubMed ID: 17532533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical significance of IL-13 and TNF-alpha in patients with chronic obstructive pulmonary disease].
    Chen BW; Cao J
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep; 19(9):557. PubMed ID: 17767831
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease.
    Piehl-Aulin K; Jones I; Lindvall B; Magnuson A; Abdel-Halim SM
    Respiration; 2009; 78(2):191-6. PubMed ID: 19270439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.